Prevention of Atrial Fibrillation Following Esophagectomy
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that the medication amiodarone decreases the incidence of
atrial fibrillation (AF) following esophagectomy surgery. Their specific aims are to:
Determine the effectiveness of amiodarone for the prevention of AF following esophagectomy
surgery; Determine the influence of the prevention of AF following esophagectomy surgery on
post-surgical duration of stay in the Intensive Care Unit ICU)and duration of post-surgical
hospital stay; and Determine the safety of amiodarone for the prevention of AF following
esophagectomy surgery.